Introduction
Methods
CMR protocol
Wall thickening
Strain analysis
Clinical outcomes
Statistical analysis
Results
Baseline characteristics
Global myocardial strain at follow-up
GLS (%) | Total (n = 166) | p value | CTO-PCI (n = 71) | No-CTO PCI (n = 95) | p value* |
Baseline | − 14.3 (6.2) | − 13.9 (6.5) | − 14.6 (6.0) | 0.53 | |
Follow-up | − 16.1 (6.0) | − 16.3 (5.8) | − 15.9 (6.1) | 0.68 | |
Change | − 1.8 (4.3) | < 0.001† | − 2.4 (4.2) | − 1.4 (4.3) | 0.14 |
GCS (%) | Total (n = 160) | p value | CTO-PCI (n = 73) | No-CTO PCI (n = 87) | p value* |
Baseline | − 19.6 (7.1) | − 19.5 (7.2) | − 19.7 (7.1) | 0.90 | |
FU | − 21.2 (7.1) | − 20.9 (6.7) | − 21.5 (7.4) | 0.60 | |
Change | − 1.7 (4.7) | < 0.001† | − 1.4 (4.5) | − 1.9 (4.9) | 0.55 |
Prognostic value of global strain
Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
Beta | 95% CI | p value | Beta | 95% CI | p value | |
Age (years) | − 0.01 | − 0.20 to 0.18 | 0.93 | |||
Male | − 1.31 | − 7.29 to 4.66 | 0.67 | |||
Diabetes | − 8.06 | − 13.00 to − 3.12 | 0.002 | |||
Infarct LAD | − 4.11 | − 7.77 to − 0.45 | 0.03 | |||
CTO LAD | 1.84 | − 2.50 to 6.18 | 0.40 | |||
CTO-PCI | 0.85 | − 2.88 to 4.57 | 0.65 | |||
Baseline LVEF (%) | 0.70 | 0.60 to 0.81 | < 0.001 | 0.45 | 0.29 to 0.60 | < 0.001 |
Baseline LVEDV (ml/m2) | − 0.22 | − 0.29 to − 0.15 | < 0.001 | − 0.08 | − 0.13 to − 0.02 | 0.005 |
MVO present | − 6.64 | − 10.18 to − 3.10 | < 0.001 | − 2.48 | − 4.81 to − 0.14 | 0.04 |
Baseline infarct size (g) | − 0.46 | − 0.61 to − 0.30 | < 0.001 | |||
Baseline GLS (%) | − 1.20 | − 1.41 to − 0.98 | < 0.001 | − 0.40 | − 0.68 to − 0.12 | 0.006 |
Baseline GCS (%) | − 1.18 | − 1.35 to − 1.00 | < 0.001 |
Segmental circumferential strain at follow-up
CTO territory | Infarct territory | |||||||
---|---|---|---|---|---|---|---|---|
Dysfunctional segments (SWT < 45%) | Total (s = 1504) | p value* | CTO-PCI (s = 223) | No-CTO PCI (s = 275) | p value* | CTO-PCI (s = 294) | No-CTO PCI (s = 316) | p value* |
Baseline | − 17.2 (9.2) | – | − 17.5 (10.0) | − 16.8 (8.9) | 0.41 | − 15.8 (8.7) | − 16.3 (9.1) | 0.46 |
Follow-up | − 19.7 (9.4) | – | − 20.2 (9.8) | − 19.3 (9.3) | 0.33 | − 19.1 (9.3) | − 18.6 (9.7) | 0.68 |
Change | − 2.4 (8.9) | < 0.001† | − 2.5 (9.5) | − 2.5 (8.5) | 0.50 | − 3.2 (9.4) | − 2.3 (9.0) | 0.42 |
Prediction of wall thickening recovery with segmental strain
Coefficient | SE | t | p value* | |
---|---|---|---|---|
Dysfunctional segments (s = 1202) | ||||
Segmental strain | − 0.31 | 0.08 | − 3.85 | < 0.001 |
Wall thickening | − 0.55 | 0.05 | − 11.96 | < 0.001 |
Infarct (TEI) | − 0.08 | 0.04 | − 1.74 | 0.08 |
MVO present | − 6.43 | 2.45 | − 2.96 | 0.003 |
CTO-PCI | 4.85 | 2.45 | 1.98 | 0.05 |
Dysfunctional segments in CTO territory (s = 498) | ||||
Segmental strain | − 0.44 | 0.14 | − 3.17 | 0.002 |
Wall thickening | − 0.45 | 0.08 | − 5.39 | < 0.001 |
Infarct (TEI) | − 0.12 | 0.08 | − 1.51 | 0.13 |
CTO-PCI | 7.73 | 3.06 | 2.53 | 0.01 |